BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 38562166)

  • 1. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review.
    Bhatt A; Mishra S; Glehen O
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):15-29. PubMed ID: 37359927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Metastatic ovarian mucinous carcinoma to the breast: diagnostic challenges and pitfalls.
    Laokulrath N; Lim SK; Lim HY; Gudi M; Tan PH
    Front Oncol; 2024; 14():1364011. PubMed ID: 38562166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous epithelial ovarian carcinoma.
    Perren TJ
    Ann Oncol; 2016 Apr; 27 Suppl 1():i53-i57. PubMed ID: 27141073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
    Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A
    Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extramammary Metastases to the Breast.
    Li J; Wahab R; Brown AL; Guarnieri B; Lewis K; Mahoney MC; Vijapura C
    Radiographics; 2023 Oct; 43(10):e230036. PubMed ID: 37708072
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin Metastases in Ovarian Malignancy: A Case Report with Literature Review.
    Pipal VR; Singh P; Pipal DK; Elhence P
    J Midlife Health; 2023; 14(1):49-52. PubMed ID: 37680376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Smithgall MC; Yemelyanova A; Mathew S; Gogineni S; He B; Zhang T; Robinson BD; Tu JJ
    Int J Gynecol Pathol; 2024 Mar; 43(2):134-139. PubMed ID: 37406458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas.
    Zhang X; Yao J; Niu N; Li X; Liu Y; Huo L; Euscher ED; Wang H; Bell D; Sood AK; Wang G; Lawson BC; Ramalingam P; Malpica A; Sahin AA; Ding Q; Liu J
    Mod Pathol; 2023 Feb; 36(2):100001. PubMed ID: 36853778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentation.
    Musa A; Joiner M; Dzul S; Miller SR
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
    Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
    J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.